Jmp securities articles
-
Blueprint Medicines (NASDAQ:BPMC) Price Target Increased to $125.00 by Analysts at JMP Securities
Blueprint Medicines (NASDAQ:BPMC – Get Free Report) had its price objective raised by JMP Securities from $114.00 to $125.00 in a report issued on Friday, Benzinga reports. The firm currently has a “market outperform” rating on the biotechnology company’s stock. JMP Securities’ target price suggests a potential upside of 16.62% from the company’s previous close. […]
-
LayerX Security Raises $24M for its Browser Security Platform, Enabling Employees to Work Securely from Any Browser, Anywhere
Tel Aviv, Israel, May 2nd, 2024, CyberNewsWire Early adoption by Fortune 100 companies worldwide, LayerX already secures more users than any other browser security solution and enables unmatched security, performance and experience LayerX, pioneer of the LayerX Browser Security platform, today announced $24 million in Series A funding led by Glilot+, the early-growth fund of
-
The Global Security Initiative: Transcending Western security dilemmas
Wang Qiuyi, vice professor at the Institute of International Relations of China Foreign Affairs University, explains how the Global Security Initiative is different from the traditional Western security vision.